These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7860804)

  • 1. Endogenous cholecystokinin is not a major regulator of food intake in the chicken.
    Choi YH; Furuse M; Satoh S; Okumura J
    J Comp Physiol B; 1994; 164(6):425-9. PubMed ID: 7860804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of the cholecystokinin-A receptor antagonist, devazepide, on the digestive system of the chicken.
    Furuse M; Choi YH; Satoh S; Okumura J
    Experientia; 1996 Apr; 52(4):353-6. PubMed ID: 8620940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the CCK receptor antagonist MK-329 on food intake in broiler chickens.
    Covasa M; Forbes JM
    Pharmacol Biochem Behav; 1994 Jun; 48(2):479-86. PubMed ID: 8090818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous cholecystokinin reduces feeding in young rats.
    Weller A; Smith GP; Gibbs J
    Science; 1990 Mar; 247(4950):1589-91. PubMed ID: 2321020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
    Guan D; Rivard N; Maouyo D; Gettys TW; Morisset J
    Regul Pept; 1993 Feb; 43(3):169-76. PubMed ID: 8441822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
    Ebenezer IS; Baldwin BA
    Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Devazepide increases food intake in male but not female Zucker rats.
    Strohmayer AJ; Greenberg D
    Physiol Behav; 1996 Jul; 60(1):273-5. PubMed ID: 8804675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin.
    Laferrere B; Nguyen M; Bonhomme G; Legall A; Basdevant A; Guy-Grand B
    Behav Neurosci; 1991 Oct; 105(5):707-11. PubMed ID: 1815620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats.
    Reidelberger RD; Varga G; Solomon TE
    Peptides; 1991; 12(6):1215-21. PubMed ID: 1815209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the CCK receptor antagonist MK-329 on food intake in pigs.
    Ebenezer IS; de la Riva C; Baldwin BA
    Physiol Behav; 1990 Jan; 47(1):145-8. PubMed ID: 2326329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms.
    Rezayat M; Oreizi S; Zarrindast MR
    Gen Pharmacol; 1997 Feb; 28(2):337-40. PubMed ID: 9013214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
    Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
    Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats.
    Reidelberger RD; Varga G; Liehr RM; Castellanos DA; Rosenquist GL; Wong HC; Walsh JH
    Am J Physiol; 1994 Oct; 267(4 Pt 2):R901-8. PubMed ID: 7524371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Devazepide alters meal patterns in lean, but not obese, male Zucker rats.
    Strohmayer AJ; Greenberg D
    Physiol Behav; 1994 Nov; 56(5):1037-9. PubMed ID: 7824568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.